A curative combination cancer therapy achieves high fractional cell killing through low cross-resistance and drug additivity.

Palmer AC, Chidley C, Sorger PK
Elife. 2019 Nov 19;8. pii: 50036. doi: 10.7554/eLife.50036. PubMed Article

Plasmids from Article

No plasmids are currently publicly available from Addgene for this article.